In polycystic kidney disease, SLC9B2 is significantly upregulated and positively correlated with cyst size, regulated by the polycystin-1/Ca2+/NFAT signaling axis, which can be induced by vasopressin and methylxanthine drugs (63). The gene discussed is SLC9B2; the disease is polycystic kidney disease.